Ark Biotech
PrivateLast Round
Grant
Aug 14, 2025
Total Funding Raised
$16.88M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ark Biotech operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Grant round in August 2025.
Ark Biotech is a biotechnology company that develops high-fidelity bioprocess simulation software to optimize cell culture processes and scale production.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Vertical SaaS, Drug Discovery, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ark Biotech Comparables
Compare Ark Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioReact | 87% | |
| PolyModels Hub | 85% | |
| DataHow AG | 84% |
For institutional investors. Book with your work email.
Ark Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 14, 2025 | ||||
| Series A | May 24, 2024 | ||||
| Seed | May 3, 2022 | ||||
| Seed | Dec 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ark Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| F4 Fund | Seed |
| The Engine | Series A, Seed |
| Hawktail Management | Seed |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| HCVC | Series A, Seed |
| BioTools Innovator | Grant |
| Lowercase Capital | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors grew 88% MoM, reaching 522.
- Aug 14, 2025
$200K grant from BioTools Innovator and PHEMCE.
For institutional investors. Book with your work email.
Ark Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ark Biotech's valuation, stock price, and market status.
Is Ark Biotech a public or private company?
Ark Biotech is a private company.
What is the current stock price of Ark Biotech?
Ark Biotech is a private company, so its shares have no public market price. Caplight tracks Ark Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ark Biotech worth (valuation)?
Valuation information for Ark Biotech is not publicly available.
Can I buy Ark Biotech stock?
Ark Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ark Biotech's last funding round?
Ark Biotech's most recent funding round was Grant on August 14, 2025.
Who are the main investors in Ark Biotech?
Key investors in Ark Biotech include F4 Fund, The Engine, Hawktail Management, Public Health Emergency Medical Countermeasures Enterprise, HCVC.
Will Ark Biotech IPO soon?
No public IPO plans have been announced for Ark Biotech.
How can I track Ark Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Ark Biotech's shares on secondary markets.